Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by RichyRich$on Dec 12, 2013 10:54am
249 Views
Post# 21998625

Pouch Easier to Get Human Trial Approval than Cell Encapsul

Pouch Easier to Get Human Trial Approval than Cell EncapsulSernova is far ahead of the game because cell pouch is easier to get human trial approval than cell encapsulation. They already have human trial approval, but the second stage approval for adding Sertolin should not be a problem because the cell pouch can simply be removed if there's a problem. But the FDA and Health Canada would be reluctant and take many years to get their human trial approval on cell encapsulation or cell re-engineering, because if something went wrong, you can't pull those cells out of the body like a cell pouch. Two years ago, Philip said the plan was to have this on the mass market in 5 years. That would be 3 years from today. Give them a bit of slack, and if it's on the market 5 years from today, none of those other research Institutes are that close. Also, a lot of those other researchers are not even with a company on the stock market. Bay Street and Wall Street want to make money and will cheer for the company that's closer and on the stock market. In the same time helping Sernova achieve it faster with more capital.
Bullboard Posts